RPS-BLAST 2.2.26 [Sep-21-2011]

Database: CDD.v3.10 
           44,354 sequences; 10,937,602 total letters

Searching..................................................done

Query= psy13594
         (574 letters)



>gnl|CDD|238073 cd00127, DSPc, Dual specificity phosphatases (DSP); Ser/Thr and Tyr
           protein phosphatases. Structurally similar to
           tyrosine-specific phosphatases but with a shallower
           active site cleft and a distinctive active site
           signature motif, HCxxGxxR. Characterized as VHR- or
           Cdc25-like.
          Length = 139

 Score = 72.6 bits (179), Expect = 2e-15
 Identities = 31/88 (35%), Positives = 47/88 (53%), Gaps = 7/88 (7%)

Query: 53  CDEVYPNIFLSDGGTAKNKEYLKRIGITHVINAAKGKKFGMVNTTSDYYKDVGIKFLGLE 112
             E+ P ++L     A +KE LK++GITHV+N AK          ++        +L + 
Sbjct: 2   LSEITPGLYLGSYPAASDKELLKKLGITHVLNVAKEVP-------NENLFLSDFNYLYVP 54

Query: 113 LLDLPIANISCHFRDVADFIEDALENNG 140
           +LDLP  +IS +F +  DFI+DA E  G
Sbjct: 55  ILDLPSQDISKYFDEAVDFIDDAREKGG 82


>gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function
           prediction only].
          Length = 517

 Score = 70.8 bits (174), Expect = 7e-13
 Identities = 31/155 (20%), Positives = 64/155 (41%), Gaps = 25/155 (16%)

Query: 400 IEGVPVDQCVDLDYE--SRKHICKLVMELCLRELFQFRYMQTDPNWSNFFYNKDTKQLIL 457
           I+G+ +     L      RK + +L++   LR+L +  +   DP+  N     D  +++L
Sbjct: 248 IDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLRDGFFHADPHPGNILVRSD-GRIVL 306

Query: 458 LDFGATRAYSKEFMDQYIQVIKAGADGDKDKEFMDQYIQVIKAGADGDKDKVLTISRKMG 517
           LDFG       +F     +++ A         F+++           D D+V  +  ++G
Sbjct: 307 LDFGIVGRLDPKFRRYLAELLLA---------FLNR-----------DYDRVAELHVELG 346

Query: 518 FLTGYESKIMEEAHVNTVMILSEVFSEKIGEFDFG 552
           ++     +    A +  V  L  ++ + + E  FG
Sbjct: 347 YVPPDTDRDPLAAAIRAV--LEPIYGKPLEEISFG 379



 Score = 42.3 bits (100), Expect = 5e-04
 Identities = 20/104 (19%), Positives = 44/104 (42%), Gaps = 18/104 (17%)

Query: 321 GVGTIAEVTRRTLGFGDSSLSVGTTLDSAF--INPANAERIVNTLCKVRGAALKIGQILS 378
            +G +  +T R          +G +  ++   +    AER+   L ++    +K+GQILS
Sbjct: 21  LLGRLLRLTGRLALLLRLLSWLGKSKLASSEELREKRAERLRLALEELGPTFIKLGQILS 80

Query: 379 IQDSNVISPELQKAFER------------VRKLIE---GVPVDQ 407
            +  +++ PE  +   +              ++IE   G P+++
Sbjct: 81  TRP-DLVPPEYAEELAKLQDRVPPFPFEEAERIIEEELGRPIEE 123


>gnl|CDD|214551 smart00195, DSPc, Dual specificity phosphatase, catalytic domain. 
          Length = 138

 Score = 55.8 bits (135), Expect = 2e-09
 Identities = 27/86 (31%), Positives = 39/86 (45%), Gaps = 9/86 (10%)

Query: 55  EVYPNIFLSDGGTAKNKEYLKRIGITHVINAAKGKKFGMVNTTSDYYKDVGIKFLGLELL 114
           E+ P+++L     A N   LK++GITHVIN                Y      +LG+ + 
Sbjct: 3   EILPHLYLGSYSDALNLALLKKLGITHVINVTNEVPN---------YNGSDFTYLGVPID 53

Query: 115 DLPIANISCHFRDVADFIEDALENNG 140
           D     IS +F +  +FIEDA    G
Sbjct: 54  DNTETKISPYFPEAVEFIEDAESKGG 79


>gnl|CDD|216117 pfam00782, DSPc, Dual specificity phosphatase, catalytic domain.
           Ser/Thr and Tyr protein phosphatases. The enzyme's
           tertiary fold is highly similar to that of
           tyrosine-specific phosphatases, except for a
           "recognition" region.
          Length = 131

 Score = 45.7 bits (109), Expect = 5e-06
 Identities = 24/82 (29%), Positives = 41/82 (50%), Gaps = 9/82 (10%)

Query: 60  IFLSDGGTAKNKEYLKRIGITHVINAAKGKKFGMVNTTSDYYKDVGIKFLGLELLDLPIA 119
           ++L    TA     L+++GITHVIN  +           +   + GI +LG+ + D    
Sbjct: 1   LYLGSYPTASKAF-LEKLGITHVINVTREV--------PNSNLNSGILYLGIPVEDNHET 51

Query: 120 NISCHFRDVADFIEDALENNGT 141
           NIS +  +  +FI+DA++  G 
Sbjct: 52  NISKYLPEAVEFIDDAIQKGGK 73


>gnl|CDD|177871 PLN02226, PLN02226, 2-oxoglutarate dehydrogenase E2 component.
          Length = 463

 Score = 36.7 bits (84), Expect = 0.035
 Identities = 14/37 (37%), Positives = 25/37 (67%)

Query: 276 RAPGAPKPIPKAKNKPQLNPVAKQRKVPSSRLGRMVS 312
           +AP +P P  ++  +PQL P  ++R+VP +RL + V+
Sbjct: 211 KAPSSPPPPKQSAKEPQLPPKERERRVPMTRLRKRVA 247


>gnl|CDD|177251 MTH00208, ND5, NADH dehydrogenase subunit 5; Provisional.
          Length = 628

 Score = 33.4 bits (77), Expect = 0.35
 Identities = 8/16 (50%), Positives = 9/16 (56%)

Query: 432 FQFRYMQTDPNWSNFF 447
           F   YM  DPN + FF
Sbjct: 126 FSHYYMSNDPNKNAFF 141


>gnl|CDD|109709 pfam00662, Oxidored_q1_N, NADH-Ubiquinone oxidoreductase (complex
           I), chain 5 N-terminus.  This sub-family represents an
           amino terminal extension of pfam00361. Only
           NADH-Ubiquinone chain 5 and eubacterial chain L are in
           this family. This sub-family is part of complex I which
           catalyzes the transfer of two electrons from NADH to
           ubiquinone in a reaction that is associated with proton
           translocation across the membrane.
          Length = 62

 Score = 28.7 bits (65), Expect = 1.1
 Identities = 8/18 (44%), Positives = 10/18 (55%)

Query: 431 LFQFRYMQTDPNWSNFFY 448
           L+   YM  DPN + FF 
Sbjct: 41  LYSIWYMSHDPNINRFFS 58


>gnl|CDD|184849 PRK14847, PRK14847, hypothetical protein; Provisional.
          Length = 333

 Score = 30.0 bits (67), Expect = 3.8
 Identities = 29/107 (27%), Positives = 46/107 (42%), Gaps = 12/107 (11%)

Query: 390 QKAFERVRKLIEG--VPVDQCVDLDYESRKHICKLVMELCLRELFQFRYMQTDPNWSNFF 447
           Q  F+ VRKLI+   +P D  ++   +SR        +L  R    F  +   P      
Sbjct: 80  QTDFDFVRKLIDERRIPDDVTIEALTQSRP-------DLIAR---TFEALAGSPRAIVHL 129

Query: 448 YNKDTKQLILLDFGATRAYSKEFMDQYIQVIKAGADGDKDKEFMDQY 494
           YN    Q   + FG +RA  KE      + I+A AD +   +++ +Y
Sbjct: 130 YNPIAPQWRRIVFGMSRAEIKEIALAGTRQIRALADANPGTQWIYEY 176


>gnl|CDD|240345 PTZ00287, PTZ00287, 6-phosphofructokinase; Provisional.
          Length = 1419

 Score = 29.6 bits (66), Expect = 5.2
 Identities = 18/63 (28%), Positives = 30/63 (47%), Gaps = 1/63 (1%)

Query: 212 SVVL-DGVKAFVFKEAGSERDVSEFEQDSQYSEPTNLEKSKLGYKKAMELTKKKDAFAVV 270
           SV+L D   AF  +E   +    +   D + SE  +    KL  KK +   + K++F +V
Sbjct: 24  SVLLRDNECAFNIEENEDQNSKDQLPCDKKDSEMIDCLMQKLTSKKFLVEKETKNSFYLV 83

Query: 271 DED 273
           D +
Sbjct: 84  DNE 86


>gnl|CDD|193577 cd09888, NGN_Euk, Eukaryotic N-Utilization Substance G (NusG)
           N-terminal (NGN) domain, including plant KTF1 (KOW
           domain-containing Transcription Factor 1).  The
           N-Utilization Substance G (NusG) protein and its
           eukaryotic homolog, Spt5, are involved in transcription
           elongation and termination. NusG contains an NGN domain
           at its N-terminus and Kyrpides Ouzounis and Woese (KOW)
           repeats at its C-terminus. Spt5 forms an Spt4-Spt5
           complex that is an essential RNA polymerase II
           elongation factor. NusG was originally discovered as an
           N-dependent antitermination enhancing activity in
           Escherichia coli, and has a variety of functions such as
           its involvement in RNA polymerase elongation and
           Rho-termination in bacteria. Orthologs of the NusG gene
           exist in all bacteria, but their functions and
           requirements are different. Spt5-like is homologous to
           the Spt5 proteins present in all eukaryotes, which is
           unique as it encodes a protein with an additional long
           carboxy-terminal extension that contains WG/GW motifs.
           Spt5-like, or KTF1 (KOW domain-containing Transcription
           Factor 1), is a RNA-directed DNA methylation (RdDM)
           pathway effector in plants.
          Length = 86

 Score = 27.5 bits (62), Expect = 5.5
 Identities = 8/25 (32%), Positives = 13/25 (52%)

Query: 211 SSVVLDGVKAFVFKEAGSERDVSEF 235
           S    DG+K +++ EA  E  V + 
Sbjct: 37  SVFARDGLKGYIYIEARKEAHVKDA 61


>gnl|CDD|233050 TIGR00609, recB, exodeoxyribonuclease V, beta subunit.  The RecBCD
           holoenzyme is a multifunctional nuclease with potent
           ATP-dependent exodeoxyribonuclease activity. Ejection of
           RecD, as occurs at chi recombinational hotspots,
           cripples exonuclease activity in favor of recombinagenic
           helicase activity. All proteins in this family for which
           functions are known are DNA-DNA helicases that are used
           as part of an exonuclease-helicase complex (made up of
           RecBCD homologs) that function to generate substrates
           for the initiation of recombination and recombinational
           repair. This family is based on the phylogenomic
           analysis of JA Eisen (1999, Ph.D. Thesis, Stanford
           University) [DNA metabolism, DNA replication,
           recombination, and repair].
          Length = 1087

 Score = 29.7 bits (67), Expect = 5.7
 Identities = 11/50 (22%), Positives = 20/50 (40%)

Query: 146 LKGVLKGLQLVANAGIKHQTLEIQQKWTNSSFKSLASNLDQSLKSTSTTP 195
           L  +L+ L     A ++ Q   I +K   +  +     L + L+    TP
Sbjct: 867 LHAILESLIFSQAADLEKQRNLIAEKLKKTGLEGWEPELQEWLEKMLNTP 916


>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine
           Kinase, c-Jun N-terminal Kinase 2.  Serine/Threonine
           Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2)
           subfamily, catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           JNK2 subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. JNKs are mitogen-activated protein kinases
           (MAPKs) that are involved in many stress-activated
           responses including those during inflammation,
           neurodegeneration, apoptosis, and persistent pain
           sensitization, among others. Vetebrates harbor three
           different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like
           JNK2, is expressed in every cell and tissue type.
           Initially it was thought that JNK1 and JNK2 were
           functionally redundant as mice deficient in either genes
           (Jnk1 or Jnk2) could survive but disruption of both
           genes resulted in lethality. However, recent studies
           have shown that JNK1 and JNK2 perform distinct functions
           through specific binding partners and substrates.  JNK2
           is specifically translocated to the mitochondria during
           dopaminergic cell death. Specific substrates include the
           microtubule-associated proteins DCX and Tau, as well as
           TIF-IA which is involved in ribosomal RNA synthesis
           regulation. Mice deficient in Jnk2 show protection
           against arthritis, type 1 diabetes, atherosclerosis,
           abdominal aortic aneurysm, cardiac cell death,
           TNF-induced liver damage, and tumor growth, indicating
           that JNK2 may play roles in the pathogenesis of these
           diseases.
          Length = 359

 Score = 28.8 bits (64), Expect = 7.4
 Identities = 27/97 (27%), Positives = 43/97 (44%), Gaps = 13/97 (13%)

Query: 383 NVISPELQKAFERVRKL---IEGVPVDQC----VDLDYESRKHICKLVMELC-LRELFQF 434
           NV +P  QK+ E  + +   +E +  + C    ++LD+E   ++  L   LC ++ L   
Sbjct: 87  NVFTP--QKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL--LYQMLCGIKHLHSA 142

Query: 435 RYMQTDPNWSNFFYNKDTKQLILLDFGATRAYSKEFM 471
             +  D   SN     D   L +LDFG  R     FM
Sbjct: 143 GIIHRDLKPSNIVVKSDCT-LKILDFGLARTACTNFM 178


>gnl|CDD|235322 PRK04950, PRK04950, ProP expression regulator; Provisional.
          Length = 213

 Score = 28.4 bits (64), Expect = 8.0
 Identities = 14/59 (23%), Positives = 25/59 (42%), Gaps = 1/59 (1%)

Query: 249 KSKLGYKKAMELTKKKDAFAVVDEDVARAPGAPKPIPKAKNKPQLNPVAKQRKVPSSRL 307
           K+K+  ++A +  KK++A     E   R    PKP    K +       + +  P S +
Sbjct: 107 KAKVQAQRAEQQAKKREAAGE-KEKAPRRERKPKPKAPRKKRKPRAQKPEPQHTPVSDI 164


>gnl|CDD|206756 cd10019, 14-3-3_sigma, 14-3-3 sigma, an isoform of 14-3-3 protein. 
           14-3-3 protein sigma isoform, also known as stratifin or
           human mammary epithelial marker (HME) 1, has been most
           directly linked to tumor development. In humans, it is
           expressed by the SFN gene, strictly in stratified
           squamous epithelial cells in response to DNA damage
           where it is transcriptionally induced in a p53-dependent
           manner, subsequently causing cell-cycle arrest at the
           G2/M checkpoint. Up-regulation and down-regulation of
           14-3-3 sigma expression have both been described in
           tumors. For example, in human breast cancer, 14-3-3
           sigma is predominantly down-regulated by CpG
           methylation, acting as both a tumor suppressor and a
           prognostic indicator, while in human scirrhous-type
           gastric carcinoma (SGC), it is up-regulated and may play
           an important role in SGC carcinogenesis and progression.
           Loss of 14-3-3 sigma expression sensitizes tumor cells
           to treatment with conventional cytostatic drugs, making
           this protein an attractive therapeutic target. 14-3-3
           domains are an essential part of 14-3-3 proteins, a
           ubiquitous class of regulatory,
           phosphoserine/threonine-binding proteins found in all
           eukaryotic cells, including yeast, protozoa and
           mammalian cells.
          Length = 242

 Score = 28.5 bits (63), Expect = 9.8
 Identities = 29/151 (19%), Positives = 68/151 (45%), Gaps = 19/151 (12%)

Query: 125 FRDVADFIEDALENNGTYVSDLKGVLK-------GLQLVA---NAGIKHQTLEIQQKWTN 174
           + D+A F++ A+E      ++ + +L        G Q  A    + I+ ++ E   +   
Sbjct: 19  YEDMAAFMKGAVEKGEELSNEERNLLSVAYKNVVGGQRAAWRVLSSIEQKSNEEGSEEKG 78

Query: 175 SSFKSLASNLDQSLKSTSTTPCALLNANVLKEAAERSSVVLDGVKAFVFKEAGSE-RDVS 233
              +     ++  L+    T   LL+++++KEA +  S      + F  K  G   R ++
Sbjct: 79  PEVREYREKVETELQGVCDTVLGLLDSHLIKEAGDAES------RVFYLKMKGDYYRYLA 132

Query: 234 EFEQDSQYSEPTNLEKSKLGYKKAMELTKKK 264
           E    +   +   ++ ++  Y++AM+++KK+
Sbjct: 133 EVA--TGDDKKRIIDSARSAYQEAMDISKKE 161


  Database: CDD.v3.10
    Posted date:  Mar 20, 2013  7:55 AM
  Number of letters in database: 10,937,602
  Number of sequences in database:  44,354
  
Lambda     K      H
   0.316    0.134    0.378 

Gapped
Lambda     K      H
   0.267   0.0743    0.140 


Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Sequences: 44354
Number of Hits to DB: 28,877,709
Number of extensions: 2864259
Number of successful extensions: 2916
Number of sequences better than 10.0: 1
Number of HSP's gapped: 2905
Number of HSP's successfully gapped: 27
Length of query: 574
Length of database: 10,937,602
Length adjustment: 102
Effective length of query: 472
Effective length of database: 6,413,494
Effective search space: 3027169168
Effective search space used: 3027169168
Neighboring words threshold: 11
Window for multiple hits: 40
X1: 16 ( 7.3 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.6 bits)
S2: 62 (27.6 bits)